A detailed history of Wayfinding Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wayfinding Financial, LLC holds 6,656 shares of ABBV stock, worth $1.3 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
6,656
Previous 6,692 0.54%
Holding current value
$1.3 Million
Previous $1.22 Million 6.32%
% of portfolio
0.71%
Previous 0.78%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $5,572 - $6,507
-36 Reduced 0.54%
6,656 $1.14 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $24,452 - $27,861
153 Added 2.34%
6,692 $1.22 Million
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $2,614 - $2,944
19 Added 0.29%
6,539 $1.01 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $15,630 - $18,094
117 Added 1.83%
6,520 $971,000
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $21,201 - $26,384
-160 Reduced 2.44%
6,403 $862,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $79,969 - $92,096
553 Added 9.2%
6,563 $1.05 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $36,237 - $43,457
-262 Reduced 4.18%
6,010 $817,000
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $2,818 - $3,232
21 Added 0.34%
6,272 $841,000
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.05%
6,251 $957,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $31,411 - $38,972
238 Added 3.96%
6,248 $954,000
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $645,654 - $816,939
6,010 New
6,010 $817,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $345B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wayfinding Financial, LLC Portfolio

Follow Wayfinding Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wayfinding Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wayfinding Financial, LLC with notifications on news.